Rare diseases
Investigational molecules
Locations
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
LithuaniaStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
LithuaniaLithuaniaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
LithuaniaA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
LithuaniaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
LithuaniaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
LithuaniaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
LithuaniaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
LithuaniaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
LithuaniaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
LithuaniaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
LithuaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
